1199SEIU Benefit Funds

Similar documents
RAHF PFM ALPHANINE SD COAGULATION FACTOR IX J7193 COAGULATION FACTOR IX (RFIXFC)

1199SEIU Benefit Funds

1199SEIU Benefit Funds

METABOLIC, IMMUNE DISORDERS OR INHERITED RARE DISEASE ALPHA-1 PROTEINASE INHIBITORS ARANESP BLOOD CELL DEFICIENCY ARANESP ARCALYST

BCBS AZ ADV PLUS * CLASSIC * PREMIER For use with members associated with the BHN Network Prior Authorization List 2015

List of Designated High-Cost Drugs

MedStar Medicare Choice Pharmacy Services

Aetna Better Health. Specialty Drug Program

Pulmonary Hypertension Weight Loss Skin Conditions. Skin Conditions Multiple Sclerosis Endocrine Disorder. Endocrine Disorder.

1199SEIU Benefit Funds

J-Code Trade Name Drug Name Required Medical Information

PRESCRIPTION DRUGS REQUIRING PRIOR AUTHORIZATION

Drug Name. J0129 Injection, abatacept (Orencia ), 10 mg Effective 01/01/2014. J0178 Injection, aflibercept (Eylea ), 1 mg Effective 04/01/2015

PRESCRIPTION DRUGS REQUIRING PRIOR AUTHORIZATION

SELF-ADMINISTERED MEDICATIONS LIST

Provider Administered Drug Program (PADP) and Physician Administered Drug VPSS List

Exclusion Reasons Presumption of Long- Term Non-Acute Administration C9399 Unclassified Drugs or

LIMITED DISTRIBUTION MEDICATIONS

SPECIALTY PHARMACY Master Clinical Drug List

DRUGS REQUIRING PRIOR AUTHORIZATION

2016 MDwise HIP Medical Services that Require Prior Authorization

Pharmacy Services Request Types

PA Category Name Code(s) Additional Notes ABA 0364T 0365T 0366T 0367T 0373T 0374T H G0396. Applied Behavioral Analysis stage 3*

Prior Authorization Program Information (Effective April 1st, 2018)

Utilization Management

Client Prior Authorization Program (CPA) PA Required (PA) Reimb Code. Reimb Code CLAIM EDIT. Reimb Code. Reimb Code. Reimb Code

2018 MDwise Excel Network Hoosier Healthwise Medical Services that Require Prior Authorization

2016 MDwise HIP Medical Services that Require Prior Authorization

MDwise Hoosier Care Connect Medical Services that Require Prior Authorization

PA Category Name Code(s) Additional Notes ABA. Applied Behavioral Analysis stage 3*

2018 MDwise Excel Network Hoosier Healthwise Medical Services that Require Prior Authorization

Drug Name Generic Name J-Code Unclassified Drugs in excess of $10,000

CENTENE PHARMACY & THERAPEUTICS COMMITTEE SECOND QUARTER 2017 AMBETTER GUIDELINE SUMMARY. Revision Summary or Description

INJECTABLE MEDICINES. Resources, Links or Additional Information. J Code Brand Names Generic names Prior Authorization or Restrictions

2017 MDwise HIP Medical Services that Require Prior Authorization

after reconstitution No Yes Refrigerate; do Not freeze. Discard unused portions; do Not save for further Immune Deficiencies & Related

2018 MDwise HIP Medical Services that Require Prior Authorization

2018 MDwise HIP Medical Services that Require Prior Authorization

2018 MDwise HIP Medical Services that Require Prior Authorization

Essential Health Benefits Standard Specialty PA and QL List July 2016

BCN Advantage SM requirements for drugs covered under the medical benefit

Specialty Pharmacy Pipeline

Medication Policy Manual. Policy No: dru408. Topic: Site of Care Review Date of Origin: July 10, 2015

Injections Requiring Prior Authorization

Specialty Drugs. The following is a list of medications that are considered to be specialty drugs. Specialty drugs

Prior Authorization Program

Specialty Drugs. The specialty drug list below is effective June 5, 2018 and is subject to change at any time.

Original Policy Date

Drug Class Prior Authorization Criteria Therapeutic Agents in Rheumatic and Inflammatory Diseases

ACAMPROSATE (CAMPRAL)

March 2017 Pharmacy & Therapeutics Committee Decisions

Percent Brand Name Generic Name Strength How Supplied NDC from AWP/SWP Adcetris. Amprya dalfampridine 10 mg 60 count bottle

2018 BCN Advantage Prior Authorization Criteria Last updated: April, 2018

FIDELIS CARE NEW YORK DEPARTMENT OF PHARMACY SERVICES J Code Prior Authorizations & Required Clinical Information 2011 (Updated 3/14/11)

Vivida Health Specialty Pharmacy Drugs (Injectable) Prior-Authorization Requirements Effective 1/1/19

Medical Policy An independent licensee of the Blue Cross Blue Shield Association

STAT Bulletin. Drug Therapy Guideline Updates. To: All Primary Care Physicians and Specialists Contracts Affected: All Lines of Business

2018 INJECTABLE DRUG PRIOR AUTHORIZATION CRITERIA

LDI integrated pharmacy services

LIST OF DRUGS THAT MAY BE COVERED UNDER YOUR MEDICAL BENEFIT

2018 BCN Advantage Prior Authorization Criteria Last updated: November, 2017

Criteria for Medical Benefit Drugs Requiring Clinical Review

Criteria for Medical Benefit Drugs Requiring Clinical Review

New Billing Guidelines for Home Infusion, Enteral and Parenteral Therapies Home Infusion Fee Schedule Effective July 1, 2009

Injectable Drugs Requiring Pre-Service Approval

The following are J Code requirements

MDwise HIP Prior Authorization and Drug List

Prescription Drug Benefit Rider V

Actemra. Products Affected ACTEMRA INTRAVENOUS. Covered Uses

2019 INJECTABLE DRUG PRIOR AUTHORIZATION CRITERIA

UPMC for You Pharmacy and Therapeutics Committee Meeting April 7, 2014 meeting

Descriptor Brand Name. Alprostadil, Caverject, Edex, Prostin VR Pediatric. Calcimar, Miacalcin

Formulary Changes. One mission: you TABLE A. FORMULARY CHANGES 7/1/2018: Commercial 3-Tier Formulary. Commercial 4-Tier Formulary

CENTENE PHARMACY THERAPEUTICS COMMITTEE THIRD QUARTER 2017 CLINICAL POLICY (BIOPHARM) SUMMARY TABLE Coverage Guideline/Policy &

Texas Medicaid Specialty Drug List Effective December 15, 2017

Prescription Drug Benefit Rider

The Effect of Current Managed Care Trends on Patient Access in 3 Specialty Classes MS, Hepatitis C & Pulmonary Arterial Hypertension

MDwise Self-Administered Codes for Medical

Pharmacy and Medical Guideline Updates

CIMZIA (certolizumab pegol)

Medication Prior Authorization Form

SUPPLEMENTARY INFORMATION

Immune Modulating Drugs Prior Authorization Request Form

Xeljanz. Xeljanz, Xeljanz XR (tofacitinib) Description

Regulatory Status FDA-approved indications: Entyvio is an α4β7integrin receptor antagonist indicated for: (1)

Quarterly Pharmacy Formulary Change Notice

Cosentyx. Cosentyx (secukinumab) Description

Regulatory Status FDA-approved indication: Orencia is a selective T cell co-stimulation modulator indicated for: (1)

ACTEMRA (tocilizumab)

Regulatory Status FDA-approved indication: Orencia is a selective T cell costimulation modulator indicated for: (1)

P&T/Formulary Committee Actions (1Q18)

Cimzia. Cimzia (certolizumab pegol) Description

Pharmacy Clinical Prior Authorization Assistance Chart Effective February 2018

Biologic Immunomodulators Prior Authorization with Quantity Limit Program Summary

Pharmacy Management Drug Policy

Biologics for Autoimmune Diseases

Specialty Pipeline Update

Transcription:

1199SEIU Benefit Funds MEDICAL BENEFIT MANAGEMENT PROGRAM SPECIALTY DRUG LIST Effective October 1, 2017 As of April 1, 2015, providers must use the web-based ExpressPAth platform to obtain prior authorization of drug treatments. Register at https://www.express-path.com. If you have questions, please call (877) 273-2122. The symbol [PA] next to a drug name indicates that this medication is subject to the Prior Authorization Program. The symbol [CPA] next to a drug name indicates that this medication is subject to the Authorization Program. The symbol [evicore] next to a drug name indicates that this medication is subject to the evicore Comprehensive Oncology Management Program. Please 1199 Brand Name Generic Description Disease State ACTEMRA TOCILIZUMAB INFLAMMATORY / CANCER PA/ EVICORE ADAGEN PEGADEMASE BOVINE ENZYME DEFICIENCIES YES J2504 ADCIRCA ADCIRCA (TADALAFIL) PULMONARY HYPERTENSION PA YES J8499 ADEMPAS RIOCIGUAT CIRCULATION PA YES J8499 ADIPEX-P PHENTERMINE WEIGHT LOSS PA YES J8499 ADVATE FACTOR VIII (ANTIHEMOPHL FCTR) HEMOPHILIA YES J7192 ADYNOVATE AFSTYLA FACTOR VIII (ANTIHEMOPHL FCTR) PEGYLATED ANTIHEMOPHL FCTR () SINGLE CHAIN YES J3262 HEMOPHILIA YES C9137, J7199, J7207 HEMOPHILIA YES C9140 ALDURAZYME LARONIDASE ENZYME DEFICIENCIES CPA NO J1931 ALPHANATE FACTOR VIII (ANTIHEMOPHL FCTR) HEMOPHILIA YES J7186 ALPHANINE SD FACTOR IX COMPLEX (HUMAN) HEMOPHILIA YES J7193 ALPROLIX FACTOR IX Fc FUSION PROTEIN HEMOPHILIA YES J7201 AMPYRA DALFAMPRIDINE MULTIPLE SCLEROSIS PA YES J8499 APOKYN APOMORPHINE HCL MISCELLANEOUS CNS YES J0364 ARALAST NP ALPHA-1-PROTEINASE INHIBITOR RESPIRATORY PA YES J0256 s where there is a Prior Authorization requirement will have claims checked against the quantities and approvals obtained in the Prior Authorization.

ARCALYST RILONACEPT CRYOPYRIN-ASSOCIATED PA YES J2793 PERIODIC SYNDROMES ARISTADA ARIPIPRAZOLE LAUROXIL INJ MENTAL YES J1942 ARIXTRA FONDAPARINUX SODIUM ANTICOAGULANT YES J1652 ATGAM LYMPHOCYTE IMMUNE GLOBULIN TRANSPLANT YES J7504 AUBAGIO TERIFLUNOMIDE MULTIPLE SCLEROSIS PA YES J8499 AUSTEDO DEUTETRABENAZINE MISCELLANEOUS CNS PA YES J8499 AVEED TESTOSTERONE UNDECANOATE ENDOCRINE PA YES J3145 AVONEX INTERFERON BETA-1A MULTIPLE SCLEROSIS PA YES J1826, Q3027 BEBULIN FACTOR IX COMPLEX (HUMAN) HEMOPHILIA YES J7194 BELVIQ LORCASERIN WEIGHT LOSS PA YES J8499 BENEFIX FACTOR VIII (ANTIHEMOPHL FCTR) HEMOPHILIA YES J7195 BENLYSTA BELIMUMAB INFLAMMATORY YES J0490 BERINERT C1 ESTERASE INHIBITOR HEREDITARY ANGIOEDEMA PA YES J0597 BETASERON INTERFERON BETA-1B MULTIPLE SCLEROSIS PA YES J1830 BIVIGAM IMMUNE GLOBULIN - IV IMMUNE DEFICIENCY PA YES 90283, J1556 BONIVA (IV) IBANDRONATE OSTEOPOROSIS PA YES J1740 BOTOX BOTULINUM TOXIN A NEUROMUSCULAR PA YES J0585 /COSMETIC BRINEURA CERLIPONASE ALFA MISCELLANEOUS SPECIALTY PA YES C9399, J3590 CARIMUNE NF IMMUNE GLOBULIN - IV IMMUNE DEFICIENCY PA YES 90283, J1566 CELLCEPT MYCOPHENOLATE MOFETIL TRANSPLANT YES J7517, J7599 CEPROTIN PROTEIN C CONCENTRATE, HUMAN MISCELLANEOUS SPECIALTY YES J2724 CERDELGA ELIGLUSTAT ENZYME DEFICIENCIES CPA YES J8499 CEREDASE ALGLUCERASE ENZYME DEFICIENCIES CPA NO J0205 CEREZYME IMIGLUCERASE ENZYME DEFICIENCIES CPA NO J1786 CHENODAL CHENODIOL MISCELLANEOUS SPECIALTY PA YES NO HCPC CIMZIA CERTOLIZUMAB PEGOL INFLAMMATORY PA YES J0717 CINQAIR RESLIZUMAB RESPIRATORY PA YES C9481, J2786 CINRYZE C1 ESTERASE INHIBITOR HEREDITARY ANGIOEDEMA PA YES J0598 COAGADEX FACTOR X HUMAN HEMOPHILIA YES J7175 s where there is a Prior Authorization requirement will have claims checked against the quantities and approvals obtained in the Prior Authorization.

CONTRAVE NALTREXONE/BUPROPRION WEIGHT LOSS PA YES J3490 COPAXONE GLATIRAMER ACETATE MULTIPLE SCLEROSIS PA YES J1595 COPEGUS RIBAVIRIN HEPATITIS C PA YES J8499 CORIFACT FACTOR XIII HEMOPHILIA YES J7180 COSENTYX SECUKINUMAB INFLAMMATORY PA YES C9399, J3590 CUVITRU IMMUNE GLOBULIN - SQ IMMUNE DEFICIENCY PA YES J3490 CYTOGAM CYTOMEGALOVIRUS IMMUNE GLOB IMMUNE DEFICIENCY YES 90291, J0850 DAKLINZA DACLATASVIR HEPATITIS C PA YES J8499 DDAVP DESMOPRESSIN ACETATE ENDOCRINE YES J2597 DEFEROXAMINE DEFEROXAMINE IRON TOXICITY YES J0895 MESYLATE DEPO-TESTOSTERONE TESTOSTERONE CYPIONATE ENDOCRINE PA YES J1071 DESFERAL DEFEROXAMINE IRON TOXICITY YES J0895 DESMOPRESSIN DESMOPRESSIN ACETATE ENDOCRINE YES J2597 ACETATE DIDREX BENZPHETAMINE WEIGHT LOSS PA YES J3490 DIETHYLPROPRION DIETHYLPROPRION WEIGHT LOSS PA YES J3490 DUPIXENT DUPILUMAB INFLAMMATORY PA YES C9399, J3590 DYLOJECT DICLOFENAC SODIUM INJ PAIN MANAGEMENT YES J1130 DYSPORT ABOBOTULINUMTOXINA NEUROMUSCULAR PA YES J0586 /COSMETIC EGRIFTA TESAMORELIN ACETATE ENDOCRINE PA YES C9399, J3490 ELAPRASE IDURSULFASE ENZYME DEFICIENCIES CPA NO J1743 ELELYSO TALIGLUCERASE ALFA ENZYME DEFICIENCIES CPA NO J3060 ELOCTATE FACTOR IX Fc FUSION PROTEIN HEMOPHILIA YES J7205 EMFLAZA DEFLAZACORT MUSCULAR DYSTROPHY PA YES J8499 ENBREL ETANERCEPT INFLAMMATORY PA YES J1438 ENTYVIO VEDOLIZUMAB INFLAMMATORY PA YES J3380 EPCLUSA SOFOSBUVIR/VELPATASVIR HEPATITIS C PA YES J8499 EPOPROSTENOL EPOPROSTENOL NA PULMONARY HYPERTENSION PA YES J1325 SODIUM ESBRIET PIRFENIDONE IDIOPATHIC PULMONARY PA YES J8499 FIBROSIS EUFLEXXA SODIUM HYALURONATE OSTEOARTHRITIS PA YES J7323 s where there is a Prior Authorization requirement will have claims checked against the quantities and approvals obtained in the Prior Authorization.

EXTAVIA INTERFERON BETA-1B MULTIPLE SCLEROSIS PA YES J1830 EYLEA AFLIBERCEPT OPHTHALMIC PA YES J0178 FABRAZYME AGALSIDASE ENZYME DEFICIENCIES CPA NO J0180 FEIBA NF ANTI-INHIBITOR COAGULANT COMP. HEMOPHILIA YES J7198 FIRAZYR ICATIBANT ACETATE HEREDITARY ANGIOEDEMA PA YES J1744 FLEBOGAMMA/ IMMUNE GLOBULIN - IV IMMUNE DEFICIENCY PA YES 90283, J1572 FLEBOGAMMA DIF FLOLAN EPOPROSTENOL NA PULMONARY HYPERTENSION PA YES J1325 FONDAPARINUX FONDAPARINUX SODIUM ANTICOAGULANT YES J1652 SODIUM FORTEO TERIPARATIDE OSTEOPOROSIS PA YES J3110 FRAGMIN DALTEPARIN (PORCINE) ANTICOAGULANT YES J1645 FUZEON ENFUVIRTIDE HIV YES J1324 GAMASTAN S-D IMMUNE GLOBULIN - IM IMMUNE DEFICIENCY YES 90281, J1460, J1560 GAMMAGARD LIQUID IMMUNE GLOBULIN - IV IMMUNE DEFICIENCY PA YES 90283, 90284, J1569 GAMMAGARD S-D IMMUNE GLOBULIN - IV IMMUNE DEFICIENCY PA YES 90283, J1566 GAMMAKED IMMUNE GLOBULIN - IV/SQ IMMUNE DEFICIENCY PA YES 90283, 90284, J1561 GAMMAPLEX IMMUNE GLOBULIN - IV IMMUNE DEFICIENCY PA YES 90283, J1557 GAMUNEX-C IMMUNE GLOBULIN - IV IMMUNE DEFICIENCY PA YES 90283, 90284, J1561 GEL-ONE HYALURONATE SODIUM OSTEOARTHRITIS PA YES J7326 GEL-SYN HYALURONATE SODIUM OSTEOARTHRITIS PA YES J7328 GENOTROPIN SOMATROPIN GROWTH DEFICIENCY PA YES J2941 GENVISC 850 HYALURONATE SODIUM OSTEOARTHRITIS PA YES Q9980, J7320 GILENYA FINGOLIMOD HYDROCHLORIDE MULTIPLE SCLEROSIS PA YES J8499 GLASSIA ALPHA-1-PROTEINASE RESPIRATORY PA YES J0257 INHIBITOR GLATOPA GLATIRAMER ACETATE MULTIPLE SCLEROSIS PA YES J1595 GRASTEK TIMOTHY GRASS POLLEN ASTHMA AND ALLERGY PA YES J3590, C9399 ALLERGEN EXTRACT H.P. ACTHAR GEL CORTICOTROPIN MISCELLANEOUS CNS YES J0800 HAEGARDA C1 ESTERASE INHIBITOR HEREDITARY ANGIOEDEMA PA YES C9399, J3590 s where there is a Prior Authorization requirement will have claims checked against the quantities and approvals obtained in the Prior Authorization.

HARVONI LEDIPASVIR/SOFOSBUVIR HEPATITIS C PA YES J8499 HELIXATE FS FACTOR VIII (ANTIHEMOPHL FCTR) HEMOPHILIA YES J7192 HEMOFIL M FACTOR VIII (ANTIHEMOPHL FCTR) HEMOPHILIA YES J7190 HEPAGAM B HEP.B IMMUNE GLOB/MALTOSE HEPATITIS B YES J1571, J1573 HETLIOZ TASIMELTEON MISC SPECIALTY PA YES J8499 HIZENTRA IMMUNE GLOBULIN- SQ IMMUNE DEFICIENCY PA YES 90284, J1559 HUMATE-P FACTOR VIII (ANTIHEMOPHL FCTR) HEMOPHILIA YES J7187 HUMATROPE SOMATROPIN GROWTH DEFICIENCY PA YES J2941 HUMIRA ADALIMUMAB INFLAMMATORY PA YES J0135 HYALGAN SODIUM HYALURONATE OSTEOARTHRITIS PA YES J7321 HYMOVIS HYALURONIC ACID OSTEOARTHRITIS PA YES C9471, J7322 HYPERHEP B S-D HEPATITIS B IMMUNE GLOBULIN HEPATITIS B YES 90371 HYPERRAB S-D RABIES IMMUNE GLOBULIN IMMUNE DEFICIENCY YES 90375 HYPERRHO S-D RHO(D) IMMUNE GLOBULIN IMMUNE DEFICIENCY YES 90384, 90385, J2788, J2790 HYQVIA IMMUNE GLOBULIN - SQ IMMUNE DEFICIENCY PA YES J1575 IDELVION FACTOR IX ALBUMIN FUSION HEMOPHILIA YES C9139, J7202 PROTEIN ILARIS CANAKINUMAB CRYOPYRIN-ASSOCIATED PA YES J0638 PERIODIC SYNDROMES IMOGAM RABIES-HT RABIES IMMUNE GLOBULIN IMMUNE DEFICIENCY YES 90376 IMPLANON ETONOGESTREL CONTRACEPTIVE YES J7307 INCRELEX MECASERMIN GROWTH DEFICIENCY PA YES J2170 INFERGEN INTERFERON ALFACON-1 HEPATITIS C YES J9212 INFLECTRA INFLIXIMAB - DYYB INFLAMMATORY PA YES Q5102 INGREZZA VALBENAZINE MISCELLANEOUS CNS PA YES J8499 IXINITY COAGULATION FACTOR IX HEMOPHILIA YES J7195 KALBITOR ECALLANTIDE HEREDITARY ANGIOEDEMA PA YES J1290 KALYDECO IVACAFTOR RESPIRATORY PA YES J8499 KANUMA SEBELIPASE ALFA ENZYME DEFICIENCIES CPA YES C9478, J2840 KCENTRA PROTHROMBIN COMPLEX HUMAN HEMOPHILIA YES C9132 KENALOG TRIAMCINOLONE ACETONIDE INFLAMMATORY YES J3301 KEVZARA SARILUMAB INFLAMMATORY PA YES C9399, J3590 s where there is a Prior Authorization requirement will have claims checked against the quantities and approvals obtained in the Prior Authorization.

KINERET ANAKINRA INFLAMMATORY / CANCER PA/ EVICORE KOATE-DVI FACTOR VIII (ANTIHEMOPHL FCTR) HEMOPHILIA YES J7190 KOGENATE FS FACTOR VIII (ANTIHEMOPHL FCTR) HEMOPHILIA YES J7192 KORLYM MIFEPRISTONE ENDOCRINE PA YES J8499 KOVALTRY FACTOR VIII (ANTIHEMOPHL FCTR) HEMOPHILIA NO J7192 KRYSTEXXA PEGLOTICASE INFLAMMATORY PA YES J2507 YES KUVAN SAPROPTERIN ENDOCRINE PA YES J8499 DIHYDROCHLORIDE KYLEENA LEVONORGESTREL CONTRACEPTIVE YES Q9984 eff. 7/1/2017 LEMTRADA ALEMTUZUMAB MULTIPLE SCLEROSIS PA YES J0202 LETAIRIS AMBRISENTAN PULMONARY HYPERTENSION PA YES J8499 LILETTA LEVONORGESTREL CONTRACEPTIVE YES J7297 LOMAIRA PHENTERMINE WEIGHT LOSS PA YES J3490 LOVENOX ENOXAPARIN ANTICOAGULANT YES J1650 LUCENTIS RANIBIZUMAB OPHTHALMIC PA YES J2778 LUMIZYME ALGLUCOSIDASE ALFA ENZYME DEFICIENCIES CPA NO J0221 MACUGEN PEGAPTANIB SODIUM OPHTHALMIC PA YES J2503 MAKENA HYDROXYPROGESTERONE CAPROATE J3590 MISC SPECIALTY PA YES J1725, Q9986 eff. 7/1/2017 MAVYRET GLECAPREVIR/PIBRENTASVIR HEPATITIS C PA YES J8499 MICRHOGAM PLUS RHO(D) IMMUNE GLOBULIN IMMUNE DEFICIENCY YES 90385, J2788 MIRENA LEVONORGESTREL CONTRACEPTIVE YES J7298 MODERIBA RIBAVIRIN HEPATITIS C YES J8499 MONOCLATE-P FACTOR VIII (ANTIHEMOPHL FCTR) HEMOPHILIA YES J7190 MONONINE FACTOR IX COMPLEX (HUMAN) HEMOPHILIA YES J7193 MONOVISC SODIUM HYALURONATE OSTEOARTHRITIS PA YES C9399, J7327 MYALEPT METRELEPTIN LIPODYSTROPHY PA YES J3590, C9399 MYCOPHENOLATE MYCOPHENOLATE MOFETIL TRANSPLANT YES J7517 MOFETIL MYFORTIC MYCOPHENOLATE SODIUM TRANSPLANT YES J7518 MYOBLOC BOTULINUM TOXIN TYPE B NEUROMUSCULAR /COSMETIC PA YES J0587 MYOZYME ALGLUCOSIDASE ALFA ENZYME DEFICIENCIES CPA NO J0220 s where there is a Prior Authorization requirement will have claims checked against the quantities and approvals obtained in the Prior Authorization.

NABI-HB HEPATITIS B IMMUNE GLOBULIN HEPATITIS B YES 90371 NAGLAZYME GALSULFASE ENZYME DEFICIENCIES CPA NO J1458 NATPARA PARATHYROID HORMONE ENDOCRINE PA YES C9399, J3590 NEXPLANON ETONOGESTREL CONTRACEPTIVE YES J7307 NORDITROPIN SOMATROPIN GROWTH DEFICIENCY PA YES J2941 NOVOEIGHT FACTOR VIII (ANTIHEMOPHL FCTR) HEMOPHILIA YES J7182 NOVOSEVEN RT FACTOR VIIA, (BHK CELLS) HEMOPHILIA YES J7189 NPLATE ROMIPLOSTIM BLOOD CELL DEFICIENCY PA YES J2796 NUCALA MEPOLIZUMAB RESPIRATORY PA YES C9473, J2182 NULOJIX BELATACEPT TRANSPLANT YES J0485 NUTROPIN SOMATROPIN GROWTH DEFICIENCY PA YES J2941 NUVARING ETONOGESTREL/ETHYINYL CONTRACEPTIVE YES J7303 ESTRADIOL NUWIQ FACTOR VIII (ANTIHEMOPHL FCTR) HEMOPHILIA YES C9138, J7209 OBIZUR ANTIHEMOPHL FCTR () HEMOPHILIA YES J7194 PORCINE SEQUENCE OCREVUS OCRELIZUMAB MULTIPLE SCLEROSIS PA YES C9399, C9494, J3590 OCTAGAM IMMUNE GLOBULIN - IV IMMUNE DEFICIENCY PA YES 90283, J1568 OCTREOTIDE ACETATE OCTREOTIDE ENDOCRINE YES J2354 OFEV NINTEDANIB IDIOPATHIC PULMONARY PA YES J8499 FIBROSIS OLYSIO SIMEPREVIR HEPATITIS C PA YES J8499 OMNITROPE SOMATROPIN GROWTH DEFICIENCY PA YES J2941 ONSOLIS FENTANYL CITRATE PAIN MANAGEMENT PA YES J8499 OPSUMIT MACITENTAN PULMONARY HYPERTENSION PA YES J8499 ORALAIR MIXED GRASS POLLENS ASTHMA AND ALLERGY PA YES J3590, C9399 ALLERGENS EXTRACT ORENCIA ABATACEPT/MALTOSE INFLAMMATORY PA YES J0129 ORENITRAM TREPROSTINIL PULMONARY HYPERTENSION PA YES J8499 ORKAMBI LUMACAFTOR/IVACAFTOR CYSTIC FIBROSIS PA YES J8499 ORTHO EVRA NORELGESTROMIN/ETHINYL CONTRACEPTIVE YES J7304 ESTRADIOL ORTHOVISC HYALURONATE SODIUM OSTEOARTHRITIS PA YES J7324 s where there is a Prior Authorization requirement will have claims checked against the quantities and approvals obtained in the Prior Authorization.

OTEZLA APREMILAST INFLAMMATORY PA YES J8499 OTIPRIO CIPROFLOXACIN ANTI-INFECTIVE PA YES J7342 PARAGARD COPPER INTRAUTERINE DEVICE CONTRACEPTIVE YES J7300 PEGASYS PEGINTERFERON ALFA-2A HEPATITIS/CANCER PA/ EVICORE PHENDIMETRAZINE PHENDIMETRAZINE WEIGHT LOSS PA YES J3490 YES S0145, J3590 PLEGRIDY PEGINTERFERON BETA-1A MULTIPLE SCLEROSIS PA YES J3590, C9399 PRALUENT ALIROCUMAB HYPERCHOLESTEROLEMIA PA YES C9399, J3590 PRIALT ZICONOTIDE ACETATE PAIN MANAGEMENT YES J2278 PRIVIGEN IMMUNE GLOBULIN - IV IMMUNE DEFICIENCY PA YES 90283, J1459 PROBUPHINE IMPLANT PROFILNINE/ PROFILNINE SD BUPRENORPHINE HCL MISCELLANEOUS SPECIALTY YES J0570 FACTOR IX COMPLEX (HUMAN) HEMOPHILIA YES J7194 PROGESTERONE PROGESTERONE ENDOCRINE YES J2675 PROGRAF TACROLIMUS TRANSPLANT YES J7507, J7525 PROLASTIN/ PROLASTIN-C ALPHA-1-PROTEINASE INHIBITOR RESPIRATORY PA YES J0256 PROLIA DENOSUMAB OSTEOPOROSIS/CANCER PA YES J0897 PROMACTA ELTROMBOPAG OLAMINE BLOOD CELL DEFICIENCY PA YES J8499 PULMOZYME DEOXYRIBONUCLEASE RESPIRATORY YES J7639 QSYMIA PHENTERMINE; TOPIRAMATE WEIGHT LOSS PA YES J8499 RADICAVA EDAVARONE AMYOTROPHIC LATERAL SCLEROSIS PA YES C9399, C9493, J3490 RAPAMUNE SIROLIMUS TRANSPLANT YES J7520 REBETOL RIBAVIRIN HEPATITIS C PA YES J8499 REBIF INTERFERON BETA-1A/ALBUMIN MULTIPLE SCLEROSIS PA YES Q3028 RECLAST ZOLEDRONIC ACID OSTEOPOROSIS/CANCER PA YES J3489 INATE FACTOR VIII (ANTIHEMOPHL FCTR) HEMOPHILIA YES J7192 REGIMEX BENZPHETAMINE WEIGHT LOSS PA YES J3490 REMICADE INFLIXIMAB INFLAMMATORY PA YES J1745 REMODULIN TREPROSTINIL SODIUM PULMONARY HYPERTENSION PA YES J3285 RENFLEXIS INFLIXIMAB - abda INFLAMMATORY PA YES C9399, J3590, Q5102 REPATHA EVOLOCUMAB HYPERCHOLESTEROLEMIA PA YES C9399, J3590 s where there is a Prior Authorization requirement will have claims checked against the quantities and approvals obtained in the Prior Authorization.

REVATIO SILDENAFIL CITRATE PULMONARY HYPERTENSION PA YES J3490, J8499 RHOGAM PLUS RHO(D) IMMUNE GLOBULIN IMMUNE DEFICIENCY YES 90384, J2790 RHOPHYLAC RHO(D) IMMUNE GLOBULIN IMMUNE DEFICIENCY YES 90384, 90386, J2791 RIBAPAK RIBAVIRIN HEPATITIS C PA YES J8499 RIBASPHERE RIBAVIRIN HEPATITIS C PA YES J8499 RIBATAB RIBAVIRIN HEPATITIS C PA YES J8499 RIBAVIRIN RIBAVIRIN HEPATITIS C PA YES J8499 RITUXAN RITUXIMAB INFLAMMATORY / CANCER PA/ EVICORE RUCONEST C1 ESTERASE INHIBITOR HEREDITARY ANGIOEDEMA PA YES J0596 SAIZEN SOMATROPIN GROWTH DEFICIENCY PA YES J2941 SANDOSTATIN OCTREOTIDE ENDOCRINE YES J2354 SANDOSTATIN LAR OCTREOTIDE ENDOCRINE YES J2353 SAXENDA LIRAGLUTIDE WEIGHT LOSS PA YES J3490 SEROSTIM SOMATROPIN GROWTH DEFICIENCY PA YES J2941 SIGNIFOR PASIREOTIDE DIASPARTATE ENDOCRINE PA YES C9399, J3490 SIGNIFOR LAR PASIREOTIDE DIASPARTATE INJ ENDOCRINE PA YES C9454, J2502 SILDENAFIL CITRATE SILDENAFIL CITRATE PULMONARY HYPERTENSION PA YES J3490, J8499 SILIQ BRODALUMAB INFLAMMATORY PA YES J3590 SIMPONI GOLIMUMAB INFLAMMATORY PA YES C9399, J3590 SIMPONI ARIA GOLIMUMAB INFLAMMATORY PA YES J1602 SIMULECT BASILIXIMAB TRANSPLANT YES J0480 SKYLA LEVONORGESTREL CONTRACEPTIVE YES J7301 SOLESTA DEXTRANOMER/HYALURONATE/ SOD MISCELLANEOUS SPECIALTY SOLIRIS ECULIZUMAB MISCELLANEOUS SPECIALTY YES J1300 SOMATULINE DEPOT LANREOTIDE ACETATE ENDOCRINE YES J1930 SOVALDI SOFOSBUVIR HEPATITIS C PA YES J8499 SPINRAZA NUSINERSEN NEUROMUSCULAR PA YES C9489 eff. 7/1/2017, C9399, J3490 STELARA USTEKINUMAB INFLAMMATORY PA YES J3357 s where there is a Prior Authorization requirement will have claims checked against the quantities and approvals obtained in the Prior Authorization. YES YES J9310 L8605

STELARA IV USTEKINUMAB INFLAMMATORY PA YES Q9989 eff. 7/1/2017, C9487 use for billing prior to 6/30/17, J3590 SUPARTZ HYALURONATE SODIUM OSTEOARTHRITIS PA YES J7321 SUPRENZA PHENTERMINE WEIGHT LOSS PA YES J3490 SYNAGIS PALIVIZUMAB RSV PREVENTION PA YES 90378 SYNVISC HYALURONATE SODIUM OSTEOARTHRITIS PA YES J7325 SYNVISC-ONE HYALURONATE SODIUM OSTEOARTHRITIS PA YES J7325 TACROLIMUS TACROLIMUS TRANSPLANT YES J7507 TALTZ IXEKIZUMAB RESPIRATORY PA YES J3490 TECFIDERA DIMETHYL FUMARATE MULTIPLE SCLEROSIS PA YES J8499 TECHNIVIE OMBITASVIR, PARITAPREVIR, HEPATITIS C PA YES J8499 AND RITONAVIR TESTOPEL TESTOSTERONE PELLET ENDOCRINE PA YES S0189 TESTOSTERONE TESTOSTERONE ENANTHATE ENDOCRINE PA YES J3121 ENANTHATE THYMOGLOBULIN LYMPHOCYTE IMMUNE GLOBULIN TRANSPLANT YES J7511 TOBI TOBRAMYCIN/SODIUM CHLORIDE RESPIRATORY YES J7682 TRACLEER BOSENTAN PULMONARY HYPERTENSION PA YES J8499 TREMFYA GUSELKUMAB INFLAMMATORY PA YES C9399, J3590 TYMLOS ABALOPARATIDE OSTEOPOROSIS PA YES C9399, J3490 TYSABRI NATALIZUMAB MULTIPLE SCLEROSIS PA YES J2323 TYVASO TREPROSTINIL (TYVASO) PULMONARY HYPERTENSION PA YES J7686 UPTRAVI SELEXIPAG PULMONARY HYPERTENSION PA YES J8499 VAPRISOL CONIVAPTAN MISCELLANEOUS SPECIALTY PA YES C9488 VELETRI EPOPROSTENOL NA PULMONARY HYPERTENSION PA YES J1325 VENTAVIS ILOPROST PULMONARY HYPERTENSION PA YES Q4074 VIEKIRA PAK OMBITASVIR, PARITAPREVIR AND HEPATITIS C PA YES J8499 RITONAVIR; DASABUVIR VIEKIRA XR OMBITASVIR, PARITAPREVIR AND RITONAVIR; DASABUVIR HEPATITIS C PA YES J8499 VIMIZIM ELOSULFASE ALFA ENZYME DEFICIENCIES CPA NO C9022, J1322 s where there is a Prior Authorization requirement will have claims checked against the quantities and approvals obtained in the Prior Authorization.

VISUDYNE VERTEPORFIN OPHTHALMIC YES J3396 VIVITROL NALTREXONE MICROSPHERES MISCELLANEOUS CNS YES J2315 VONVENDI VON WILLEBRAND FACTOR HEMOPHILIA YES J7179 (INANT) VOSEVI SOFOSBUVIR; VELPATASVIR; VOXILAPREVIR HEPATITIS C PA YES J8499 VPRIV VELAGLUCERASE ALFA ENZYME DEFICIENCIES CPA NO J3385 WINRHO SDF RHO(D) IMMUNE GLOBULIN IMMUNE DEFICIENCY YES 90384, 90386, J2792 XELJANZ TOFACITINIB INFLAMMATORY PA YES J8499 XENAZINE TETRABENAZINE MISCELLANEOUS CNS PA YES J8499 XENICAL ORLISTAT WEIGHT LOSS PA YES J3490 XEOMIN INCOBOTULINUMTOXINA NEUROMUSCULAR PA YES J0588 /COSMETIC XGEVA DENOSUMAB CANCER EVICORE YES J0897 XIAFLEX COLLAGENASE CLOSTRIDIUM HIST. MISCELLANEOUS SPECIALTY YES J0775 XOLAIR OMALIZUMAB RESPIRATORY PA YES J2357 XULANE XYNTHA/XYNTHA SOLOFUSE NORELGESTROMIN/ETHINYL CONTRACEPTIVE YES J7304 ESTRADIOL FACTOR VIII (ANTIHEMOPHL FCTR) HEMOPHILIA YES J7185 ZAVESCA MIGLUSTAT ENZYME DEFICIENCIES CPA YES J8499 ZEMAIRA ALPHA-1-PROTEINASE INHIBITOR RESPIRATORY PA YES J0256 ZEPATIER ELBASVIR/GRAZOPREVIR HEPATITIS C PA YES J8499 ZINBRYTA DACLIZUMAB MULTIPLE SCLEROSIS PA YES C9399, J3590 ZINPLAVA BEZLOTOXUMAB INFECTIOUS DISEASE YES C9490 ZOLEDRONIC ACID ZOLEDRONIC ACID OSTEOPOROSIS/CANCER PA YES J3489 ZOMACTON SOMATROPIN GROWTH DEFICIENCY PA YES J2941 ZOMETA ZOLEDRONIC ACID OSTEOPOROSIS/CANCER PA YES J3489 ZORBTIVE SOMATROPIN GROWTH DEFICIENCY PA YES J2941 s where there is a Prior Authorization requirement will have claims checked against the quantities and approvals obtained in the Prior Authorization.